| Dr Abhay K Suda, MD | |
|
170 Kinnelon Rd, Suite 28, Kinnelon, NJ 07405-2347 | |
| (973) 838-1717 | |
| (973) 838-1775 |
| Full Name | Dr Abhay K Suda |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 52 Years |
| Location | 170 Kinnelon Rd, Kinnelon, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962454967 | NPI | - | NPPES |
| 380900520 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MA34985 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chilton Medical Center | Pompton plains, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Care Partners Llc | 2860665809 | 76 |
News Archive
In humans, much is already known about the impact of maternal undernutrition during pregnancy, and its impact on growth, development and disease throughout the life course. However, until recently little was known about the effects of the nutritional environment around the time of conception.
For a malignant tumor to form, cancer cells must evade the immune system's attack. Numerous studies have already shown that cancer spreads particularly aggressively if there is an unfavorable balance between suppressing and active immune cells in the tumor microenvironment. "But we didn't know whether this is a consequence of an aggressive tumor or rather its cause," says Rudolf Kaaks, epidemiologist at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
Seropositive individuals —people who received antibodies after COVID-19 infection — may be able to safely delay their second mRNA vaccine dose after all, according to the results of a new study.
› Verified 9 days ago
| Entity Name | Primary Care Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083900526 PECOS PAC ID: 2860665809 Enrollment ID: O20111108000032 |
News Archive
In humans, much is already known about the impact of maternal undernutrition during pregnancy, and its impact on growth, development and disease throughout the life course. However, until recently little was known about the effects of the nutritional environment around the time of conception.
For a malignant tumor to form, cancer cells must evade the immune system's attack. Numerous studies have already shown that cancer spreads particularly aggressively if there is an unfavorable balance between suppressing and active immune cells in the tumor microenvironment. "But we didn't know whether this is a consequence of an aggressive tumor or rather its cause," says Rudolf Kaaks, epidemiologist at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
Seropositive individuals —people who received antibodies after COVID-19 infection — may be able to safely delay their second mRNA vaccine dose after all, according to the results of a new study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abhay K Suda, MD 170 Kinnelon Rd, Suite 28, Kinnelon, NJ 07405-2347 Ph: (973) 838-1717 | Dr Abhay K Suda, MD 170 Kinnelon Rd, Suite 28, Kinnelon, NJ 07405-2347 Ph: (973) 838-1717 |
News Archive
In humans, much is already known about the impact of maternal undernutrition during pregnancy, and its impact on growth, development and disease throughout the life course. However, until recently little was known about the effects of the nutritional environment around the time of conception.
For a malignant tumor to form, cancer cells must evade the immune system's attack. Numerous studies have already shown that cancer spreads particularly aggressively if there is an unfavorable balance between suppressing and active immune cells in the tumor microenvironment. "But we didn't know whether this is a consequence of an aggressive tumor or rather its cause," says Rudolf Kaaks, epidemiologist at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
Seropositive individuals —people who received antibodies after COVID-19 infection — may be able to safely delay their second mRNA vaccine dose after all, according to the results of a new study.
› Verified 9 days ago
Dr. Igor Z Avagyan, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 397 Ski Trl, Kinnelon, NJ 07405 Phone: 917-494-8226 Fax: 212-426-1409 | |
Nina Suda, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 170 Kinnelon Road Suite 28, Kinnelon, NJ 07405 Phone: 973-838-1717 Fax: 973-838-1775 | |
Dr. Viju Vijaysadan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 170 Kinnelon Rd, Suite 28, Kinnelon, NJ 07405 Phone: 973-838-7650 Fax: 973-838-1775 | |
Barry E. Levant, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 15 Kiel Ave, Kinnelon, NJ 07405 Phone: 973-838-4098 Fax: 973-838-7628 |